Business Context and Reporting Period
This Form 6-K filing by GlaxoSmithKline plc covers the period ending August 2010. The report serves as a notification of a transaction involving a director or person discharging managerial responsibility, specifically regarding changes in share interests.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This document is a regulatory notification of a specific share transaction rather than a financial performance report.
Material Changes
The material change reported is the exercise of an equity award by Mr. M Dunoyer. On August 4, 2010, he exercised an award over 12,006 Ordinary shares under the Company's Annual Incentive Plan at a price of £11.33 per share.
Guidance, Outlook, and Risks
The filing contains no management commentary, financial guidance, outlook, or discussion of risks and contingencies. It strictly details the transaction notified in accordance with Disclosure and Transparency Rule 3.1.4R(1)(a).
Key Facts for Investor Verification
- Transaction Date: August 4, 2010
- Individual: Mr. M Dunoyer
- Instrument: Annual Incentive Plan award
- Volume: 12,006 Ordinary shares
- Exercise Price: £11.33 per share
- Notification Date: August 5, 2010